![Generex Biotechnology Corp. Logo](/news-release/logo/216771/0/216771.jpg?lastModified=12%2F09%2F2016%2022%3A59%3A49&size=2)
Generex Awarded Two New Patents for Its Proprietary Buccal Drug Delivery System
June 01, 2010 09:30 ET
|
Generex Biotechnology Corp.
WORCESTER, Mass., June 1, 2010 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (Nasdaq:GNBT) (www.generex.com), the leader in drug delivery for metabolic diseases through the inner lining of the...
![Generex Biotechnology Corp. Logo](/news-release/logo/216771/0/216771.jpg?lastModified=12%2F09%2F2016%2022%3A59%3A49&size=2)
Generex Biotechnology to Participate in American Society of Clinical Oncology Annual Meeting in Chicago
May 26, 2010 09:30 ET
|
Generex Biotechnology Corp.
WORCESTER, Mass., May 26, 2010 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (Nasdaq:GNBT) (www.generex.com) today announced that its wholly owned subsidiary, Antigen Express, Inc....
![Generex Biotechnology Corp. Logo](/news-release/logo/216771/0/216771.jpg?lastModified=12%2F09%2F2016%2022%3A59%3A49&size=2)
Generex Biotechnology Announces Publication of Novel Immunotherapeutic Cancer Vaccine Results in Patients With Prostate Cancer
May 18, 2010 10:04 ET
|
Generex Biotechnology Corp.
WORCESTER, Mass., May 18, 2010 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (Nasdaq:GNBT) announced today publication of results from the first Phase I study of its lead immunotherapeutic...
![Generex Biotechnology Corp. Logo](/news-release/logo/216771/0/216771.jpg?lastModified=12%2F09%2F2016%2022%3A59%3A49&size=2)
Generex Biotechnology Hosts Satellite Symposium at CODHy 2010
May 13, 2010 09:30 ET
|
Generex Biotechnology Corp.
WORCESTER, Mass., May 13, 2010 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (Nasdaq:GNBT) (www.generex.com), the leader in drug delivery for metabolic diseases through the inner lining of the...
![Generex Biotechnology Corp. Logo](/news-release/logo/216771/0/216771.jpg?lastModified=12%2F09%2F2016%2022%3A59%3A49&size=2)
Generex Biotechnology Achieves Enrollment of Over 400 Subjects in Phase III Generex Oral-lyn(TM) Study
May 10, 2010 09:10 ET
|
Generex Biotechnology Corp.
WORCESTER, Mass., May 10, 2010 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (Nasdaq:GNBT) (www.generex.com), the leader in drug delivery for metabolic diseases through the inner lining of the...
![Generex Biotechnology Corp. Logo](/news-release/logo/216771/0/216771.jpg?lastModified=12%2F09%2F2016%2022%3A59%3A49&size=2)
Generex Receives NASDAQ Non-Compliance Notice
May 07, 2010 17:18 ET
|
Generex Biotechnology Corp.
WORCESTER, Mass., May 7, 2010 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (Nasdaq:GNBT) (www.generex.com) today announced that on May 6, 2010 the Company was notified by the NASDAQ staff...
![Generex Biotechnology Corp. Logo](/news-release/logo/216771/0/216771.jpg?lastModified=12%2F09%2F2016%2022%3A59%3A49&size=2)
Generex Receives New US Patent for Its Proprietary Buccal Drug Delivery Platform Technologies
April 29, 2010 09:30 ET
|
Generex Biotechnology Corp.
WORCESTER, Mass., April 29, 2010 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (Nasdaq:GNBT) (www.generex.com), the leader in drug delivery for metabolic diseases through the inner lining of...
![Generex Biotechnology Corp. Logo](/news-release/logo/216771/0/216771.jpg?lastModified=12%2F09%2F2016%2022%3A59%3A49&size=2)
Generex Announces Updated Phase I Results From Novel Immunotherapeutic Vaccine Presented at the European Association of Urology Congress
April 27, 2010 09:30 ET
|
Generex Biotechnology Corp.
WORCESTER, Mass., April 27, 2010 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (Nasdaq:GNBT) (www.generex.com) today announced presentation of additional results from a recently completed...
![Generex Biotechnology Corp. Logo](/news-release/logo/216771/0/216771.jpg?lastModified=12%2F09%2F2016%2022%3A59%3A49&size=2)
Generex Establishes Action Plan for Reimbursement Coverage for Generex Oral-lyn(TM)
April 19, 2010 09:30 ET
|
Generex Biotechnology Corp.
WORCESTER, Mass., April 19, 2010 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (Nasdaq:GNBT) (www.generex.com), the leader in drug delivery for metabolic diseases through the inner lining of...
![Generex Biotechnology Corp. Logo](/news-release/logo/216771/0/216771.jpg?lastModified=12%2F09%2F2016%2022%3A59%3A49&size=2)
Generex Announces New Treatment IND Site for the USFDA Expanded Access Treatment IND Program for Generex Oral-lyn(tm) in the United States
April 13, 2010 09:30 ET
|
Generex Biotechnology Corp.
WORCESTER, Mass., April 13, 2010 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (Nasdaq:GNBT) (www.generex.com), the leader in drug delivery for metabolic diseases through the inner lining of...